Marjan Farid
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marjan Farid
Marjan Farid was last confirmed as Board Member at KALA BIO, Inc. (KALA) in a filing dated December 30, 2025. Earlier roles on record: Board Member at KALA BIO, Inc. (KALA) until December 19, 2025. KALA BIO, Inc. reported in an 8-K filed February 2, 2026 that Marjan Farid resigned as Class I director, effective December 19, 2025.
“on December 19, 2025, each of (i) Marjan Farid, M.D. and Andrew I. Koven, who were Class I directors of the Company, (ii) Mark Iwicki and Todd Bazemore were Class II directors of the Company, and (iii) C. Daniel Meyers and Howard B. Rosen, who were Class III directors of the Company (collectively, the "Resigning Directors"), tendered their resignations as directors of the Company, effective immediately following the Annual Meeting and upon approval of the Issuance Proposal and the Share Increase Proposal”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-12-30
Last confirmed by a filing; no departure on record
-
Start not stated–2025-12-19
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.